[3H]azidodantrolene: Synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum

Sanjay S. Palnitkar; Bin Bin; Leslie S. Jimenez; Hiromi Morimoto; Philip G. Williams; Kalanethee Paul-Pletzer; Jerome Parness

doi:10.1021/jm9805079

[³H]azidodantrolene: Synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum

Sanjay S. Palnitkar, Bin Bin, Leslie S. Jimenez, Hiromi Morimoto, Philip G. Williams, Kalanethee Paul-Pletzer, Jerome Parness

School of Arts and Sciences, Chemistry & Chemical Biology

Rutgers, The State University

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

Dantrolene sodium is a medically important hydantoin derivative that interferes with release of Ca²⁺ from intracellular stores of skeletal muscle by an unknown mechanism. Identification of the molecular target of dantrolene would greatly aid in understanding both the mechanism of action of the drug and the dynamics of intracellular Ca²⁺ release in muscle. [³H]Azidodantrolene was designed and synthesized as a photoaffinity analogue in order to identify a putative dantrolene receptor in skeletal muscle. Introduction of 1 mole-atom of tritium into aldehyde 5b was required during radioligand synthesis in order to ensure high enough specific activity for detection of photo-cross-linked proteins by fluorographic methods. This was accomplished by reduction of ester 3 with custom synthesized, 100% tritium- labeled lithium triethylborotritide, followed by oxidation to 5b by manganese(IV) oxide. Compound 6b was demonstrated to be ≥95% tritium- labeled at the imine position by NMR spectroscopy, and the specific radioactivity of [³H]azidodantrolene sodium was empirically determined, by HPLC and liquid scintillation counting to be 24.4 Ci/mmol, ~85% of theoretical maximum. [³H]Azidodantrolene was found to be pharmacologically active in ligand-receptor binding studies with skeletal muscle sarcoplasmic reticulum membranes. Photo-cross-linking experiments analyzed by SDS-PAGE and tritium fluorography have identified a ~160-kDa specifically labeled protein as the putative, intracellular, skeletal muscle dantrolene receptor. This photolabeled protein comigrates with a protein in Western blots immunologically cross-reactive to a polyclonal anti-rabbit skeletal muscle ryanodine receptor antibody. Thus, the putative dantrolene receptor may be related to the skeletal muscle ryanodine receptor.

Original language	American English
Pages (from-to)	1872-1880
Number of pages	9
Journal	Journal of medicinal chemistry
Volume	42
Issue number	11
DOIs	https://doi.org/10.1021/jm9805079
State	Published - Jun 3 1999

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/jm9805079

Cite this

@article{8e230317ffa64d888b494514d682fe9d,

title = "[3H]azidodantrolene: Synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum",

abstract = "Dantrolene sodium is a medically important hydantoin derivative that interferes with release of Ca2+ from intracellular stores of skeletal muscle by an unknown mechanism. Identification of the molecular target of dantrolene would greatly aid in understanding both the mechanism of action of the drug and the dynamics of intracellular Ca2+ release in muscle. [3H]Azidodantrolene was designed and synthesized as a photoaffinity analogue in order to identify a putative dantrolene receptor in skeletal muscle. Introduction of 1 mole-atom of tritium into aldehyde 5b was required during radioligand synthesis in order to ensure high enough specific activity for detection of photo-cross-linked proteins by fluorographic methods. This was accomplished by reduction of ester 3 with custom synthesized, 100% tritium- labeled lithium triethylborotritide, followed by oxidation to 5b by manganese(IV) oxide. Compound 6b was demonstrated to be ≥95% tritium- labeled at the imine position by NMR spectroscopy, and the specific radioactivity of [3H]azidodantrolene sodium was empirically determined, by HPLC and liquid scintillation counting to be 24.4 Ci/mmol, ~85% of theoretical maximum. [3H]Azidodantrolene was found to be pharmacologically active in ligand-receptor binding studies with skeletal muscle sarcoplasmic reticulum membranes. Photo-cross-linking experiments analyzed by SDS-PAGE and tritium fluorography have identified a ~160-kDa specifically labeled protein as the putative, intracellular, skeletal muscle dantrolene receptor. This photolabeled protein comigrates with a protein in Western blots immunologically cross-reactive to a polyclonal anti-rabbit skeletal muscle ryanodine receptor antibody. Thus, the putative dantrolene receptor may be related to the skeletal muscle ryanodine receptor.",

author = "Palnitkar, {Sanjay S.} and Bin Bin and Jimenez, {Leslie S.} and Hiromi Morimoto and Williams, {Philip G.} and Kalanethee Paul-Pletzer and Jerome Parness",

year = "1999",

month = jun,

day = "3",

doi = "10.1021/jm9805079",

language = "American English",

volume = "42",

pages = "1872--1880",

journal = "Journal of medicinal chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "11",

}

TY - JOUR

T1 - [3H]azidodantrolene

T2 - Synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum

AU - Palnitkar, Sanjay S.

AU - Bin, Bin

AU - Jimenez, Leslie S.

AU - Morimoto, Hiromi

AU - Williams, Philip G.

AU - Paul-Pletzer, Kalanethee

AU - Parness, Jerome

PY - 1999/6/3

Y1 - 1999/6/3

N2 - Dantrolene sodium is a medically important hydantoin derivative that interferes with release of Ca2+ from intracellular stores of skeletal muscle by an unknown mechanism. Identification of the molecular target of dantrolene would greatly aid in understanding both the mechanism of action of the drug and the dynamics of intracellular Ca2+ release in muscle. [3H]Azidodantrolene was designed and synthesized as a photoaffinity analogue in order to identify a putative dantrolene receptor in skeletal muscle. Introduction of 1 mole-atom of tritium into aldehyde 5b was required during radioligand synthesis in order to ensure high enough specific activity for detection of photo-cross-linked proteins by fluorographic methods. This was accomplished by reduction of ester 3 with custom synthesized, 100% tritium- labeled lithium triethylborotritide, followed by oxidation to 5b by manganese(IV) oxide. Compound 6b was demonstrated to be ≥95% tritium- labeled at the imine position by NMR spectroscopy, and the specific radioactivity of [3H]azidodantrolene sodium was empirically determined, by HPLC and liquid scintillation counting to be 24.4 Ci/mmol, ~85% of theoretical maximum. [3H]Azidodantrolene was found to be pharmacologically active in ligand-receptor binding studies with skeletal muscle sarcoplasmic reticulum membranes. Photo-cross-linking experiments analyzed by SDS-PAGE and tritium fluorography have identified a ~160-kDa specifically labeled protein as the putative, intracellular, skeletal muscle dantrolene receptor. This photolabeled protein comigrates with a protein in Western blots immunologically cross-reactive to a polyclonal anti-rabbit skeletal muscle ryanodine receptor antibody. Thus, the putative dantrolene receptor may be related to the skeletal muscle ryanodine receptor.

AB - Dantrolene sodium is a medically important hydantoin derivative that interferes with release of Ca2+ from intracellular stores of skeletal muscle by an unknown mechanism. Identification of the molecular target of dantrolene would greatly aid in understanding both the mechanism of action of the drug and the dynamics of intracellular Ca2+ release in muscle. [3H]Azidodantrolene was designed and synthesized as a photoaffinity analogue in order to identify a putative dantrolene receptor in skeletal muscle. Introduction of 1 mole-atom of tritium into aldehyde 5b was required during radioligand synthesis in order to ensure high enough specific activity for detection of photo-cross-linked proteins by fluorographic methods. This was accomplished by reduction of ester 3 with custom synthesized, 100% tritium- labeled lithium triethylborotritide, followed by oxidation to 5b by manganese(IV) oxide. Compound 6b was demonstrated to be ≥95% tritium- labeled at the imine position by NMR spectroscopy, and the specific radioactivity of [3H]azidodantrolene sodium was empirically determined, by HPLC and liquid scintillation counting to be 24.4 Ci/mmol, ~85% of theoretical maximum. [3H]Azidodantrolene was found to be pharmacologically active in ligand-receptor binding studies with skeletal muscle sarcoplasmic reticulum membranes. Photo-cross-linking experiments analyzed by SDS-PAGE and tritium fluorography have identified a ~160-kDa specifically labeled protein as the putative, intracellular, skeletal muscle dantrolene receptor. This photolabeled protein comigrates with a protein in Western blots immunologically cross-reactive to a polyclonal anti-rabbit skeletal muscle ryanodine receptor antibody. Thus, the putative dantrolene receptor may be related to the skeletal muscle ryanodine receptor.

UR - http://www.scopus.com/inward/record.url?scp=0033519451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033519451&partnerID=8YFLogxK

U2 - 10.1021/jm9805079

DO - 10.1021/jm9805079

M3 - Article

C2 - 10354395

SN - 0022-2623

VL - 42

SP - 1872

EP - 1880

JO - Journal of medicinal chemistry

JF - Journal of medicinal chemistry

IS - 11

ER -

[³H]azidodantrolene: Synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this